Equity of $98.1B against liabilities of $207.2B implies a leverage ratio of roughly 2.1x and a debt-to-equity of 0.70, consistent with an adequately capitalized carrier though statutory RBC data is not included in the supplied snapshot.
UnitedHealth Group Incorporated (UNH) balance sheet — 30-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Assets | 312.78B | 309.58B | 298.28B | 273.72B | 245.71B | 212.21B | 197.29B | 173.89B | 152.22B | 139.06B | 122.68B | 111.38B | 86.38B | 81.88B | 80.89B | 67.89B | 63.06B | 59.05B | 55.81B | 50.9B | 48.32B | 41.37B | 27.88B | 17.63B | 14.16B | 12.49B | 11.05B | 10.27B | 9.7B | 7.62B | 7B |
| Asset Growth % | 4.3% | 3.79% | 8.97% | 11.4% | 15.79% | 7.56% | 13.46% | 14.23% | 9.47% | 13.35% | 10.14% | 28.94% | 5.5% | 1.23% | 19.14% | 7.65% | 6.8% | 5.79% | 9.66% | 5.34% | 16.79% | 48.41% | 58.1% | 24.5% | 13.44% | 12.96% | 7.59% | 5.9% | 27.26% | 8.95% | 13.56% |
| Total Investment Assets | 4M | 58.01B | 56.16B | 51.81B | 48.27B | 45.65B | 44.1B | 40.47B | 35.97B | 31.85B | 26.71B | 20.78B | 20.57B | 21.54B | 20.74B | 18.74B | 16.78B | 14.55B | 14.15B | 13.42B | 10.26B | 9.56B | 8.26B | 7.21B | 5.2B | 4.16B | 3.63B | 3.11B | 2.78B | 3.29B | 2.42B |
| Long-Term Investments | 226.82B | 54.25B | 52.35B | 47.61B | 43.73B | 43.11B | 41.24B | 37.21B | 32.51B | 28.34B | 23.87B | 18.79B | 18.83B | 19.61B | 17.71B | 16.17B | 14.71B | 13.31B | 13.37B | 12.67B | 9.64B | 8.97B | 7.75B | 6.73B | 4.5B | 3.89B | 3.43B | 2.57B | 2.61B | 2.79B | 1.8B |
| Short-Term Investments | 2.7B | 3.76B | 3.8B | 4.2B | 4.55B | 2.53B | 2.86B | 3.26B | 3.46B | 3.51B | 2.85B | 1.99B | 1.74B | 1.94B | 3.03B | 2.58B | 2.07B | 1.24B | 783M | 754M | 620M | 590M | 514M | 486M | 701M | 270M | 200M | 546M | 170M | 506M | 610.57M |
| Total Current Assets | 85.59B | 90.58B | 85.78B | 78.44B | 69.07B | 61.76B | 53.72B | 42.63B | 38.69B | 37.08B | 33.75B | 31.64B | 23.56B | 20.38B | 21.05B | 20.35B | 18.39B | 18.2B | 14.99B | 15.54B | 16.04B | 10.64B | 8.24B | 6.12B | 5.17B | 4.95B | 4.41B | 4.57B | 4.28B | 2.19B | 2.74B |
| Cash & Equivalents | 25.84B | 24.36B | 25.31B | 25.43B | 23.36B | 21.38B | 16.92B | 10.98B | 10.87B | 11.98B | 10.43B | 10.92B | 7.5B | 7.28B | 8.41B | 9.43B | 9.12B | 9.8B | 7.43B | 8.87B | 10.32B | 5.42B | 3.99B | 2.26B | 1.13B | 1.54B | 1.42B | 1.6B | 1.64B | 750M | 1.04B |
| Receivables | 198.31B | 52.72B | 48.45B | 38.97B | 30.45B | 28.08B | 12.87B | 11.82B | 11.39B | 9.57B | 8.15B | 6.52B | 4.25B | 3.05B | 5.6B | 4.55B | 3.7B | 3.79B | 3.64B | 2.9B | 1.32B | 1.21B | 906M | 745M | 664M | 856M | 867M | 912M | 965M | 768M | 605.8M |
| Other Current Assets | 8.93B | 9.75B | 8.21B | 9.84B | 10.71B | 4.45B | 21.07B | 16.57B | 12.98B | 12.03B | 12.32B | 12.21B | 10.07B | 8.12B | 3.24B | 2.09B | 2.01B | 1.84B | 1.69B | 2.6B | 3.78B | 3.42B | 2.83B | 2.36B | 2.29B | 1.96B | 1.92B | 1.5B | 1.5B | 169M | 486.57M |
| Goodwill & Intangibles | 525.32B | 130.97B | 130B | 118.93B | 107.75B | 85.84B | 82.19B | 76.01B | 68.23B | 63.05B | 56.13B | 52.84B | 36.61B | 35.45B | 35.97B | 26.77B | 25.66B | 24.3B | 22.42B | 18.59B | 18.73B | 18.23B | 10.68B | 3.69B | 3.48B | 2.81B | 2.91B | 2.86B | 2.52B | 2.28B | 2.14B |
| Goodwill | 112.97B | 110.5B | 106.73B | 103.73B | 93.35B | 75.8B | 71.34B | 65.66B | 58.91B | 54.56B | 47.58B | 44.45B | 32.94B | 31.6B | 31.29B | 23.98B | 22.75B | 20.73B | 20.09B | 16.85B | 16.82B | 16.21B | 9.47B | 3.51B | 3.36B | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 20.38B | 20.47B | 23.27B | 15.19B | 14.4B | 10.04B | 10.86B | 10.35B | 9.32B | 8.49B | 8.54B | 8.39B | 3.67B | 3.84B | 4.68B | 2.79B | 2.91B | 3.58B | 2.33B | 1.74B | 1.9B | 2.02B | 1.21B | 180M | 122M | 2.81B | 2.91B | 2.86B | 2.52B | 2.28B | 2.14B |
| PP&E (Net) | 10.95B | 10.76B | 10.55B | 11.45B | 10.13B | 8.97B | 8.63B | 8.7B | 8.46B | 7.01B | 5.9B | 4.86B | 4.42B | 4.01B | 3.94B | 2.52B | 2.2B | 946M | 2.18B | 2.12B | 1.89B | 1.65B | 1.14B | 1.03B | 955M | 847M | 303M | 278M | 294M | 364M | 312.98M |
| Other Assets | 24.82B | 23.01B | 19.59B | 17.3B | 12.26B | 107.33B | 102.33B | 94.05B | 81.02B | 1.39B | 276M | 2.39B | 2.42B | 2.01B | 1.75B | 1.62B | 1.71B | 2.29B | 2.44B | 1.59B | 1.45B | 1.25B | -277M | 64M | 52M | 3.89B | 3.43B | 2.57B | 2.61B | 2.79B | 1.8B |
| Total Liabilities | 207.24B | 207.88B | 195.69B | 174.8B | 159.36B | 135.73B | 126.75B | 111.73B | 95.99B | 87.03B | 82.27B | 75.92B | 52.54B | 48.56B | 47.59B | 39.6B | 37.24B | 35.44B | 35.03B | 30.84B | 27.51B | 23.64B | 17.16B | 12.51B | 9.74B | 8.6B | 7.37B | 6.41B | 5.66B | 3.09B | 3.17B |
| Total Debt | 74.33B | 78.39B | 76.9B | 67.44B | 57.62B | 46B | 43.47B | 40.68B | 36.55B | 31.69B | 32.97B | 32.09B | 17.41B | 16.86B | 16.75B | 11.64B | 11.14B | 11.17B | 12.79B | 11.01B | 7.46B | 7.11B | 4.02B | 1.98B | 1.76B | 1.58B | 1.21B | 991M | 708M | 19M | 30.76M |
| Net Debt | 48.49B | 54.02B | 51.59B | 42.01B | 34.26B | 24.63B | 26.55B | 29.69B | 25.69B | 19.71B | 22.54B | 21.17B | 9.91B | 9.58B | 8.35B | 2.21B | 2.02B | 1.37B | 5.37B | 2.14B | -2.86B | 1.69B | 32M | -283M | 631M | 44M | -210M | -614M | -936M | -731M | -1.01B |
| Long-Term Debt | 68.71B | 72.32B | 72.36B | 58.26B | 54.51B | 42.38B | 38.65B | 36.81B | 34.58B | 28.84B | 25.78B | 25.33B | 16.01B | 14.89B | 14.04B | 10.66B | 8.66B | 9.01B | 11.34B | 9.06B | 5.97B | 3.83B | 3.35B | 1.75B | 950M | 900M | 650M | 400M | 249M | 19M | 30.76M |
| Short-Term Debt | 5.62B | 6.07B | 4.54B | 5.31B | 3.11B | 3.62B | 4.82B | 3.87B | 1.97B | 2.86B | 7.19B | 6.63B | 1.4B | 1.97B | 2.71B | 982M | 2.48B | 2.16B | 1.46B | 1.95B | 1.48B | 3.26B | 673M | 229M | 811M | 684M | 559M | 591M | 459M | 0 | 0 |
| Total Current Liabilities | 115.83B | 114.9B | 103.77B | 99.05B | 89.24B | 78.29B | 72.42B | 61.78B | 53.21B | 50.46B | 49.22B | 42.9B | 30.62B | 27.88B | 27.12B | 23.92B | 23.7B | 22.16B | 20.19B | 18.49B | 18.5B | 16.64B | 11.33B | 8.77B | 8.38B | 7.49B | 6.57B | 5.89B | 5.34B | 2.57B | 2.64B |
| Accounts Payable | 78.91B | 77.37B | 68.56B | 31.96B | 56.77B | 49.13B | 44.37B | 40.7B | 36.6B | 33.05B | 29.75B | 26.32B | 21.29B | 19.03B | 17.99B | 16.65B | 9.22B | 9.36B | 8.66B | 8.33B | 8.08B | 7.26B | 5.54B | 5.73B | 5.2B | 0 | 0 | 0 | 0 | 0 | 73.08M |
| Deferred Revenue | 3.4B | 3.41B | 3.32B | 3.35B | 3.08B | 2.57B | 2.84B | 2.62B | 2.4B | 2.27B | 1.97B | 2.14B | 1.97B | 1.6B | 1.5B | 1.23B | 1.53B | 1.22B | 0 | 0 | 3.71B | 3.3B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 27.91B | 28.05B | 27.35B | 58.43B | 26.28B | 22.98B | 20.39B | 14.6B | 12.24B | 12.29B | 10.3B | 7.8B | 5.96B | 5.28B | 4.91B | 5.06B | 3.98B | 3.14B | 4.38B | 4.56B | 1.51B | -465M | 3.01B | 2.81B | 2.37B | 2.14B | 1.7B | 1.38B | 1.15B | 510M | 562.3M |
| Deferred Taxes | 10.54B | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 |
| Other Liabilities | 20.16B | 18.25B | 15.94B | 11.94B | 12.84B | 15.05B | 15.68B | 13.14B | 8.2B | 7.74B | 7.28B | 4.11B | 3.85B | 3.99B | 3.98B | 2.44B | 0 | 0 | 2.29B | 1.85B | 1.85B | 1.76B | 1.67B | 1.52B | 0 | 0 | 0 | 0 | 0 | 500M | 500M |
| Total Equity | 105.55B | 101.7B | 102.59B | 98.92B | 86.35B | 76.48B | 70.54B | 62.16B | 56.23B | 52.02B | 40.41B | 35.46B | 33.84B | 33.32B | 33.3B | 28.29B | 25.82B | 23.61B | 20.78B | 20.06B | 20.81B | 17.73B | 10.72B | 5.13B | 4.43B | 3.89B | 3.69B | 3.86B | 4.04B | 4.53B | 3.82B |
| Equity Growth % | 0.13% | -0.87% | 3.71% | 14.56% | 12.9% | 8.42% | 13.48% | 10.56% | 8.08% | 28.74% | 13.95% | 4.78% | 1.55% | 0.08% | 17.7% | 9.55% | 9.4% | 13.6% | 3.57% | -3.59% | 17.35% | 65.47% | 108.99% | 15.81% | 13.8% | 5.5% | -4.53% | -4.33% | -10.94% | 18.6% | 19.92% |
| Shareholders Equity | 98.1B | 94.11B | 92.66B | 88.76B | 77.77B | 71.76B | 65.49B | 57.62B | 51.7B | 49.83B | 38.4B | 33.73B | 32.45B | 32.15B | 31.18B | 28.29B | 25.82B | 23.61B | 20.78B | 20.06B | 20.81B | 17.73B | 10.72B | 5.13B | 4.43B | 3.89B | 3.69B | 3.86B | 4.04B | 4.53B | 3.82B |
| Minority Interest | 7.45B | 7.59B | 9.93B | 10.16B | 8.57B | 4.72B | 5.05B | 4.55B | 4.53B | 2.19B | 2.01B | 1.74B | 1.39B | 1.18B | 2.12B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 102.02B | 95.6B | 96.04B | 95.77B | 86.16B | 77.13B | 69.3B | 61.18B | 55.85B | 48.73B | 40.95B | 37.13B | 33.84B | 33.05B | 30.66B | 27.82B | 25.56B | 23.34B | 20.78B | 18.93B | 14.38B | 10.26B | 7.48B | 4.92B | 4.1B | 3.81B | 3.6B | 3.44B | 2.88B | 3.1B | 2.68B |
| Common Stock | 9M | 9M | 9M | 9M | 9M | 10M | 10M | 9M | 10M | 10M | 10M | 10M | 10M | 10M | 10M | 10M | 11M | 11M | 12M | 13M | 13M | 14M | 6M | 6M | 6M | 3M | 3M | 3M | 2M | 2M | 1.85M |
| Accumulated OCI | -3.93B | -2.06B | -3.39B | -7.03B | -8.39B | -5.38B | -3.81B | -3.58B | -4.16B | -2.67B | -2.68B | -3.33B | -1.39B | -908M | 438M | 461M | 252M | 253M | -52M | 98M | 15M | 33M | 132M | 149M | 148M | 44M | 90M | 165M | 44M | 29M | -6.99M |
| Return on Equity (ROE) | 15.18% | 11.8% | 14.3% | 24.16% | 24.71% | 23.51% | 23.21% | 23.38% | 22.15% | 22.85% | 18.5% | 16.78% | 16.73% | 16.89% | 17.94% | 19% | 18.75% | 17.22% | 14.58% | 22.77% | 21.58% | 21.67% | 32.65% | 34.64% | 32.5% | 24.09% | 19.49% | 14.38% | -3.87% | 11.01% | 10.14% |
| Return on Assets (ROA) | 5.1% | 3.97% | 5.04% | 8.62% | 8.79% | 8.44% | 8.3% | 8.49% | 8.23% | 8.07% | 6% | 5.88% | 6.68% | 6.91% | 7.43% | 7.85% | 7.59% | 6.66% | 5.58% | 9.38% | 9.27% | 8.9% | 11.37% | 10.41% | 10.15% | 7.76% | 6.9% | 5.69% | -1.92% | 6.29% | 5.41% |
| Equity / Assets | 33.74% | 32.85% | 34.39% | 36.14% | 35.14% | 36.04% | 35.75% | 35.75% | 36.94% | 37.41% | 32.94% | 31.84% | 39.18% | 40.7% | 41.17% | 41.67% | 40.95% | 39.98% | 37.23% | 39.42% | 43.07% | 42.86% | 38.44% | 29.08% | 31.26% | 31.16% | 33.37% | 37.6% | 41.62% | 59.48% | 54.64% |
| Debt / Equity | 0.70x | 0.77x | 0.75x | 0.68x | 0.67x | 0.60x | 0.62x | 0.65x | 0.65x | 0.61x | 0.82x | 0.91x | 0.51x | 0.51x | 0.50x | 0.41x | 0.43x | 0.47x | 0.62x | 0.55x | 0.36x | 0.40x | 0.38x | 0.39x | 0.40x | 0.41x | 0.33x | 0.26x | 0.18x | 0.00x | 0.01x |
| Book Value per Share | 117.01 | 111.76 | 110.43 | 105.46 | 90.89 | 80.00 | 73.40 | 64.35 | 57.20 | 52.81 | 41.74 | 36.67 | 34.32 | 32.57 | 31.83 | 26.03 | 22.83 | 20.02 | 16.74 | 14.74 | 14.84 | 13.30 | 8.14 | 4.15 | 3.49 | 2.98 | 2.74 | 2.72 | 2.65 | 2.97 | 2.57 |
| Tangible BV per Share | -30.83 | -32.17 | -29.51 | -21.33 | -22.53 | -9.79 | -12.13 | -14.33 | -12.22 | -11.19 | -16.24 | -17.98 | -2.81 | -2.08 | -2.55 | 1.40 | 0.15 | -0.59 | -1.32 | 1.08 | 1.49 | -0.37 | 0.03 | 1.17 | 0.74 | 0.83 | 0.58 | 0.71 | 1.00 | 1.47 | 1.13 |
Quick answers to the most common questions about buying UNH stock.
As of 2025, UnitedHealth Group Incorporated (UNH) had total assets of $309.58B including $90.58B in current assets.
UnitedHealth Group Incorporated (UNH) carries total debt of $78.39B, offset by $28.12B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
UnitedHealth Group Incorporated (UNH) has total shareholders' equity (book value) of $94.11B ($111.76 book value per share). Book value represents the net worth of the company belonging to common stock holders.
UnitedHealth Group Incorporated (UNH) reported a current ratio of 0.79x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Medicare Advantage reserve and DOJ exposure
Metrics are mathematically derived from official filings.
Equity Base Recovering From Trough
Based on UNH's reported figures, total equity climbed from $89.4B in 2024Q2 to a peak of $104.5B in 2026Q2 before easing to $98.1B in 2026Q3, suggesting capital generation is real but has been partially absorbed by claims volatility and shareholder returns. The trajectory points to a balance sheet that is strengthening over the longer window but has not yet compounded steadily.
Total assets expanded from $286.1B to $312.8B over the ten quarters, while liabilities grew more slowly in proportion, which is consistent with retained earnings rebuilding the equity cushion. The quarter-over-quarter decline in equity during 2026Q3 coincides with the spike in claims outflows, which may indicate that reserve-driven cash requirements are competing with capital accumulation. Investors should monitor whether equity stabilizes above the $100B level as reserve development normalizes.
Loss Ratio Volatility Signals Reserve Sensitivity
As reported in quarterly financial statements, UNH's loss ratio swung from 67.3% in 2026Q2 to 83.7% in 2025Q4 and 80.5% in 2026Q3, a range wide enough to suggest reserve estimates and medical cost trends are moving the earnings base materially.
Such dispersion in the loss ratio is more consistent with prior-year development and utilization timing than with a steady run-rate of medical costs, which warrants further investigation into the reserve roll-forward. The combined ratio's movement from 91.7% to 99.7% and back to 94.2% reinforces that underwriting margins remain exposed to cost resets. Analysts should strip prior-period adjustments before drawing conclusions about current-period claims inflation.
Equity Cushion Covers Liability Growth
Based on UNH's reported figures, equity of $98.1B against liabilities of $207.2B yields a leverage ratio of roughly 2.1x, a level that appears consistent with an adequately capitalized carrier though statutory RBC data is not included in the supplied snapshot.
The balance sheet does not display the excess capital cushion that would support aggressive buybacks or large acquisitions without further scrutiny, given the recent equity dip. Statutory capital adequacy cannot be confirmed from the provided data, so conclusions about buffer capacity remain inferential. Investors should monitor RBC disclosures and whether equity recovers toward its mid-2026 peak.
Claims Outflows Test Liquid Asset Base
As reported in the quarterly cash flow data, claims and loss payments rose from $75.4B in 2026Q2 to $90.7B in 2026Q3, a step-up of roughly 20% that appears to absorb a large share of the premium inflow base and tests the company's near-term liquidity buffer.
Cash and short-term liquidity figures are not separately reported in the supplied balance sheet data, so the claims-paying coverage ratio cannot be measured directly, which limits confidence in liquidity conclusions. The concentration of cash demands in a single quarter may suggest that float timing rather than structural weakness is driving the outflow pattern. Investors should watch whether claims payments normalize toward the lower end of the recent range.
Regulatory Exposure Could Reverse Equity Gains
Ongoing DOJ scrutiny of Medicare Advantage coding practices represents a contingent exposure that a beat-and-raise quarter such as the reported 2026Q3 EPS of $4.56 does not eliminate, and that could pressure equity given the recent $6.3B decline from peak.
The recent equity contraction occurs alongside an elevated Medicare Advantage utilization backdrop, and any penalty or restatement tied to coding practices could impair the equity base faster than operating earnings rebuild it. Because the magnitude and timing of potential penalties are not disclosed in the supplied data, this remains an analytical risk rather than a quantified liability. Investors should treat the strong recent EPS as partially dependent on reserve timing until regulatory outcomes are clearer.